generic names for glp-1 drugs There's still no Ozempic, but a lower-priced daily injected is coming List of approved and pending
Description
doi: 10.2147/dddt.s31443

Semaglutide (Ozempic and Wegovy) resulted in a 14.9% reduction in body weight in clinical trials, while tirzepatide (Mounjaro and Zepbound) led to a 20.9% body weight reduction

This review aims to distinguish between GLP-1RAs and DPP-4 inhibitors, and discuss when each may be favoured in clinical practice
doi: 10.1093/brain/awaa262

J.et al (2016)
